SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Clinical trials for SLL (SMALL LYMPHOCYTIC LYMPHOMA) explained in plain language.
Never miss a new study
Get alerted when new SLL (SMALL LYMPHOCYTIC LYMPHOMA) trials appear
Sign up with your email to follow new studies for SLL (SMALL LYMPHOCYTIC LYMPHOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for leukemia patients Who've run out of options
Disease control Not yet recruitingThis early-stage trial is testing a new oral drug called MS-553 in adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or stopped responding to other treatments. The main goal is to check the drug's safety and see what side effect…
Matched conditions: SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Phase: PHASE1, PHASE2 • Sponsor: MingSight Pharmaceuticals, Inc • Aim: Disease control
Last updated Apr 04, 2026 03:21 UTC
-
New drug showdown for Tough-to-Treat blood cancer
Disease control Not yet recruitingThis study aims to find out which of two daily pill treatments works better for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or stopped responding to a previous standard treatment. About 306 participants will be randomly as…
Matched conditions: SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Phase: PHASE3 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC